
Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis®) in adults aged â¥40 years not receiving a diphtheria-
Keywords: AE; adverse event; CI; confidence interval; eCRFs; electronic case report forms; ELISA; enzyme-linked immunosorbent assay; FHA; filamentous haemagglutinin; FIM2&3; fimbriae types 2 and 3; FAS; full analysis set; GMC; geometric mean antibody concentration;